Pharmaceutical company, Phosphagenics, has announced the
commencement of animal studies on its anti-cancer compound, which
claims to destroy diseased cells while not affecting normal ones by
primarily acting as a signalling molecule...
Scientists have created the nanotechnology equivalent of a Trojan
horse to smuggle a powerful chemotherapeutic drug inside tumour
cells - increasing the drug's cancer-killing activity and reducing
its toxic side effects.
Cytopia has received the green light to trial a promising new drug
that could prove effective in the fight against advanced solid
tumours. In animal studies, the drug candidate has already shown
efficacy in killing cancer cells in...
Researchers have found a protein, which plays a significant role in
colorectal carcinoma. The protein blocks the ability of tumours to
activate a natural self-destruct mechanism that would clear the
cancer from the body.
Cyclacel researchers and collaborators have solved the 3-D atomic
structure of human Proliferating Cell Nuclear Antigen (PCNA), a
protein involved in cancer. The discovery should prove crucial in
designing and developing drugs that...
The first grants given in the UK for drug development in early
phase clinical experiments have been awarded to gene therapy trials
that may herald a breakthrough in intra-abdominal cancer which has
an average survival rate of less...